MDS Pharma Services Opens Largest Phase I Clinic on U.S. ...( New 300-bed facility in Tempe Ar...),Health

New 300-bed facility in Tempe, Arizona, raises MDS capacity in the

Phoenix-area to 420 total beds

KING OF PRUSSIA, PA, Jan. 25 /PRNewswire-FirstCall/ - MDS Pharma Services (http://www.mdsps.com), a leading provider of innovative drug discovery and development solutions, has expanded its presence in the Phoenix area with a new 300-bed Phase I facility in nearby Tempe, Arizona. The $25 million facility more than doubles the previous MDS Phase I capacity in Phoenix to 420 total beds to meet the growing needs of its pharmaceutical and biotech clients. Part of an extensive global network of European and North American Phase I locations, the new facility brings the MDS Pharma Services global total to more than 1,100 beds.

In addition to a specialized area for conducting cardiac safety trials, the new facility also offers specialized ophthalmic capabilities, as well as a range of other specialty Phase I services. Purpose-built from the ground up to be a Phase I clinic, the new facility has a state-of-the art clinical lab and secure pharmacy, comfortable accommodations for study participants and well-appointed areas for visiting clients.

"Client needs were top-of-mind when we decided to expand in Phoenix - the fastest growing urban area in the United States," said MDS Pharma Services President David Spaight. "The Phoenix location offers several advantages to our clients, including travel convenience, access to a large and varied study participant pool, and an experienced and educated workforce to staff the new clinic and laboratory."

The workforce for the new facility is drawn from the same experienced team that operated the earlier MDS Pharma Services Phoenix clinic, where they achieved a better than 97% on-time study start-up record. MDS Pharma Services has had a Phase I operation in Phoenix for more than two decades, conducting more than 600 clinical trials invol
'/>"/>